Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Coronavirus Update: How Should Remdesivir Be Priced? ICER Are In Two Minds
Plus Moderna and Daiichi Sankyo Updates
Gilead will be heartened by the 'cost recovery' model, but new dexamethasone data is likely to have the biggest impact.
More from Business
More from Scrip